Wei Zhang
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$1.6MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $1.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2016 | NIH | SBIR Phase I Patient iPSC derived neural synaptic screen for drug discovery | $225K | JuvoBio Pharmaceuticals Inc. |
| Aug 31, 2016 | NIH | SBIR Phase I Patient iPSC derived neural synaptic screen for drug discovery | $225K | JuvoBio Pharmaceuticals Inc. |
| Aug 16, 2016 | NIH | SBIR Phase I Temporal Single Cell RNAseq to Identify Genes and Pathways Affected by 15q11.2 Duplication in Autism iPSC-Derived Differentiating Cortical Neurons | $224K | JuvoBio Pharmaceuticals Inc. |
| Aug 16, 2016 | NIH | SBIR Phase I Temporal Single Cell RNAseq to Identify Genes and Pathways Affected by 15q11.2 Duplication in Autism iPSC-Derived Differentiating Cortical Neurons | $224K | JuvoBio Pharmaceuticals Inc. |
| Jul 15, 2016 | NIH | SBIR Phase I High throughput multiplexed assay for profiling gene expressions of schizophrenia iPSC-derived neurons | $225K | JuvoBio Pharmaceuticals Inc. |
| Jul 15, 2016 | NIH | SBIR Phase I High throughput multiplexed assay for profiling gene expressions of schizophrenia iPSC-derived neurons | $225K | JuvoBio Pharmaceuticals Inc. |
| Feb 1, 2016 | NIH | SBIR Phase I High throughput multiplexed assay for chemicals affecting neuron differentiation | $225K | JuvoBio Pharmaceuticals Inc. |
Peer ranks
Federal funding#1,315
Awards as PI#250
Patents#273
Companies
- JuvoBio Pharmaceuticals Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.